Aceso Life Science Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is April - March.

Millions HKD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 28, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	966	369	1,174	1,314	472	1,574
Market Cap Growth	445.00%	-68.55%	-10.67%	178.13%	-69.98%	28.51%
PS Ratio	-17.24	-5.20	106.70	6.35	2.78	-12.20
PB Ratio	2.61	0.50	0.65	0.51	0.17	0.52
P/FCF Ratio	8.32	24.61	-	6.92	1.82	9.60
P/OCF Ratio	8.40	21.71	-	6.14	1.50	8.79
Debt / Equity Ratio	3.32	3.09	1.51	1.14	1.07	0.95
Debt / FCF Ratio	10.59	153.40	-	15.38	11.62	17.51
Net Debt / Equity Ratio	2.50	2.81	1.25	0.90	0.81	0.69
Net Debt / FCF Ratio	7.96	139.27	-47.27	12.21	8.85	12.72
Quick Ratio	1.87	0.26	0.56	0.49	0.73	1.49
Current Ratio	1.98	0.28	0.57	0.70	0.93	1.93
Asset Turnover	-	-	0.00	0.03	0.03	-
Return on Equity (ROE)	-51.44%	-79.55%	-36.87%	-7.70%	-20.41%	-12.63%
Return on Assets (ROA)	-16.94%	-25.33%	-14.59%	-3.31%	-9.59%	-6.21%
Return on Invested Capital (ROIC)	-19.21%	-7.64%	-4.46%	-1.59%	-2.32%	-8.67%
Earnings Yield	-38.53%	-242.49%	-39.36%	-20.09%	-78.32%	-23.89%
FCF Yield	12.01%	4.06%	-4.09%	14.46%	54.82%	10.42%
Buyback Yield / Dilution	-0.98%	1.06%	0.60%	1.63%	-6.06%	-21.39%